Evidence map›Paper›PMID 41467840›Full record

ReviewJournal of virology2026

Enterovirus D68 receptor usage: from static attachment to dynamic entry.

Dongxue Liu, Zhilin Ji, Xiangyu Zheng, Huiming Xia, Wanshan Yang, Peng-Fei Ge, Wei Wei

Abstract readReview
In one paragraph

Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dongxue Liu *Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin, China.
Zhilin Ji *Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China.ORCID 0009-0002-2488-4632
Xiangyu Zheng *Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Huiming XiaInstitute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin, China.
Wanshan YangDepartment of Pathology, Medical College, Yanbian University, Yanji, Jilin, China.
Peng-Fei GeDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China.
Wei WeiInstitute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin, China.ORCID 0000-0003-4456-840X

Funding

MOST | National Natural Science Foundation of China (NSFC) 32222005
6 · The paper itself

Abstract

Enterovirus D68 (EV-D68) is a globally reemerging respiratory pathogen of notable clinical concern due to its association with severe respiratory disease and the paralytic complication acute flaccid myelitis (AFM). Viral tropism and pathogenesis are critically dictated by interactions with host cell receptors. Our understanding of this process has evolved from a simple model of sialic acid dependence to a dynamic paradigm involving a repertoire of attachment factors and proteinaceous entry receptors. This review synthesizes the evolving landscape of EV-D68 receptor usage. We detail the well-established role of α2,6-linked sialic acid as an attachment factor and uncoating trigger for historical strains. We further discuss the discovery of intracellular adhesion molecule-5 (ICAM-5) as a neuron-specific receptor that provides a molecular explanation for neurotropism in AFM. A pivotal recent advance is the identification of major facilitator superfamily domain-containing 6 (MFSD6) as an essential entry receptor for a broad range of EV-D68 strains in both respiratory and neuronal cells. We explore the implications of this receptor versatility, whereby the virus can switch between or co-opt sialic acid, ICAM-5, and MFSD6, a plasticity that influences tissue tropism and viral evolution. Finally, we highlight how these mechanistic insights, particularly the characterization of the MFSD6 interface, are paving the way for novel therapeutic strategies, such as engineered decoy receptors, and outline key future directions in the field.

Indexed as

Enterovirus D, HumanEnterovirus InfectionsReceptors, VirusVirus AttachmentVirus InternalizationAnimalsCentral Nervous System Viral DiseasesHumansMyelitisN-Acetylneuraminic AcidNeuromuscular DiseasesNeuronsViral TropismN-Acetylneuraminic AcidReceptors, Virusacute flaccid myelitisenterovirus D68ICAM-5MFSD6sialic acidviral entryviral receptor

Identifiers

PMID41467840
PMCPMC12911884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.